Stevens Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Stevens Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-11,595	Closed	-$174K	–	1222
2016 Q1	$174K	Buy	+11,595	New	+$194K	0.01%	780
2015 Q3	–	Sell	-37,870	Closed	-$541K	–	1330
2015 Q2	$541K	Buy	+37,870	New	+$641K	0.02%	596
2014 Q1	–	Sell	-11,057	Closed	-$111K	–	1428
2013 Q4	$111K	Buy	+11,057	New	+$126K	﹤0.01%	964

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Stevens Capital Management's NXTM Position: Q2 2016 in Review

Stevens Capital Management sold out of NxStage Medical Inc. (NXTM) in Q2 2016, closing a stake of 11,595 shares — an estimated $174K sold.

Stevens Capital Management first reported a position in NXTM in Q4 2013 and held it in 3 quarters. The position peaked at $541K in Q2 2015. 147 funds tracked by Wall St. Rank hold NXTM as of Q2 2016.

Stevens Capital Management reported no remaining NxStage Medical Inc. position as of Q2 2016 after selling out during the quarter.
Stevens Capital Management sold 11,595 NxStage Medical Inc. shares in Q2 2016, an estimated $174K.
Stevens Capital Management first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 3 quarters.
Stevens Capital Management's NxStage Medical Inc. position peaked at $541K in Q2 2015.
147 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2016.

Based on Stevens Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.